Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- neuro epithelial Escherichia
- Product Overview:
Nestin, also known as neuroepithelial stem cell protein, is a type VI intermediate filament protein.{55198} Nestin monomers are comprised of a short N-terminal head domain that is required for assembly of intermediate filaments, an ?-helical rod domain that mediates dimerization, and a long C-terminal tail.{55198} They form heterodimers and heterotetramers with other intermediate filament proteins, including vimentin and ?-internexin, for assembly into intermediate filaments.{55198,55199} Nestin is found in a variety of tissue types but is expressed primarily in nervous tissue during embryonic development in mammals and has been used as a marker of neural stem/progenitor cells (NSPCs).{55199,55200} Nestin synthesis decreases as nervous tissues differentiate, however, nestin-positive neural stem cells are found in the subventricular zone (SVZ) and hippocampal dentate gyrus in the adult mammalian brain. Nestin is also expressed in a variety of tumor types and cancer stem cells, as well as in cerebellar Purkinje cells from patients with Creutzfeldt-Jakob disease (CJD).{55200,55201} Cayman’s Nestin Monoclonal Antibody can be used for immunocytochemistry (ICC), immunohistochemistry (IHC), and Western blot (WB) applications. The antibody recognizes a nestin doublet at approximately 220 to 240 kDa from human, mouse, and rat samples.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.